Kimberly Stone

Papers

Total Citations

H-Index

About

Kimberly Stone is a leading thoracic surgical oncologist whose research focuses on optimizing patient-centered outcomes in early-stage lung cancer treatment. Her work bridges the critical gap between oncologic efficacy and quality of life, particularly for patients who are not candidates for traditional lobectomy. Stone’s most cited study, a 2024 longitudinal analysis, directly compares quality-of-life trajectories following sublobar resection versus stereotactic body radiation therapy (SBRT) for early-stage non–small cell lung cancer. This landmark investigation, which has already garnered 9 citations, provides essential evidence for shared decision-making by revealing how these two standard-of-care alternatives differentially impact patients’ physical, emotional, and social well-being over time. By prioritizing patient-reported outcomes in a population often excluded from major trials, Stone has advanced a more holistic approach to thoracic oncology. Her work is particularly impactful for elderly or medically compromised patients, where treatment trade-offs are most pronounced. Through rigorous comparative effectiveness research, Stone continues to shape clinical guidelines and empower clinicians to tailor lung cancer therapy not just to the tumor, but to the whole person.